2021
  
  
    2020
  
  
    2019
  
  
    2018
  
  
    2017
  
  
    2016
  
  
    2015
  
  
    2014
  
  
    2013
  
									
									
									- 
												Oct 08, 2018BioQ Pharma Announces Positive Closure of EU Regulatory Procedure for Ready-to-Use Propofol Product
- 
												Aug 03, 2018BioQ Pharma to Present at the 38th Annual Canaccord Genuity Growth Conference
- 
												Jul 25, 2018BioQ Pharma Announces Marijn Dekkers as New Strategic Advisor to the Company
- 
												Jun 14, 2018BioQ Pharma and Xantis Pharma Join to Offer Three Ready-to-Use Infusion Products in the Czech Republic and Slovakia
- 
												May 29, 2018BioQ Pharma and POA Pharma Announce Strategic Partnership to Commercialize Three Ready-to-Use Infusion Products in the Nordic Region
- 
												May 21, 2018BioQ Pharma Receives CE Mark for Second Infusion System
- 
												Mar 23, 2018BioQ Pharma to Present at the 17th Annual Needham Healthcare Conference
- 
												Nov 20, 2017BioQ Pharma and Sophos Biotech Enter into Strategic Partnership for Post-Operative Analgesia Therapy in Italy
- 
												Sep 05, 2017Cooper Pharma and BioQ Pharma Enter into Strategic Partnership for Ropivacaine ReadyfusOR in Morocco
- 
												Aug 23, 2017STADA Australia and BioQ Pharma Enter into Strategic Partnership to Commercialize Three Ready-to-Use Infusion Products
- 
												May 16, 2017BioQ Pharma to Present at the UBS Global Healthcare Conference
- 
												Apr 04, 2017BioQ Pharma and Lunatus Add a Third Infusion Pharmaceutical to Commercial Agreement Covering Arabian Gulf Area and Middle East
- 
												Mar 30, 2017BioQ Pharma to Present at the 16th Annual Needham Healthcare Conference
- 
												Mar 17, 2017BioQ Pharma to Present at the 27th Annual Oppenheimer Healthcare Conference
- 
												Mar 14, 2017BioQ Pharma Receives Australian Regulatory Approval for Ropivacaine ReadyFusOR
- 
												Dec 06, 2016BioQ Pharma Enters into Strategic Partnership with Galen Limited to Commercialize Three Ready-to-Use Infusion Products in the United Kingdom and Ireland
- 
												Jun 08, 2016BioQ Pharma to Present at the JMP Securities Life Sciences Conference
- 
												Apr 28, 2016BioQ Pharma Expands U.S. License and Supply Agreement to Commercialize Third Ready-to-Use Infusion Product
- 
												Apr 05, 2016BioQ Pharma to Present at the 15th Annual Needham Healthcare Conference
- 
												Jan 06, 2016BioQ Pharma and Cipla Enter Into an Agreement to Commercialize BioQ’s Ropivacaine Infusion System in India
- 
												Dec 02, 2015BioQ Pharma and Lunatus Execute Agreement to Commercialize Two Infusion Pharmaceuticals in Saudi Arabia, the United Arab Emirates, Qatar and Kuwait
- 
												Nov 30, 2015BioQ Pharma to Present at the 26th Annual Oppenheimer Healthcare Conference
- 
												Oct 26, 2015BioQuiddity Changes Name to BioQ Pharma
- 
												Aug 24, 2015BioQuiddity and Lee's Pharmaceutical Enter Agreement to Jointly Commercialize Two Infusion Pharmaceuticals in China, Taiwan, Hong Kong, and Macau
- 
												Jul 22, 2015BioQuiddity Appoints Daniel Tassé to its Board of Directors
- 
												May 13, 2015BioQuiddity Enters Into an Exclusive License and Supply Agreement with Sandoz to Commercialize Two Ready‐to‐Use Infusion Products in the United States
